T1	Treatment 12 54	fimasartan/hydrochlorothiazide combination
T2	Treatment 107 130	fimasartan monotherapy.
T3	Treatment 221 237	fimasartan alone
T4	Treatment 251 300	fimasartan/hydrochlorothiazide (HCTZ) combination
T5	Treatment 387 397	fimasartan
T6	Treatment 495 516	once-daily fimasartan
T7	Treatment 564 618	once-daily fimasartan 60 mg/HCTZ 12.5 mg or fimasartan
T8	Treatment 676 702	from fimasartan 60 mg/HCTZ
T9	Treatment 711 736	to fimasartan 120 mg/HCTZ
T10	Treatment 748 763	from fimasartan
T11	Treatment 770 783	to fimasartan
T12	Treatment 916 935	The fimasartan/HCTZ
T13	Treatment 1000 1014	the fimasartan
T14	Treatment 1197 1222	BP in the fimasartan/HCTZ
T15	Treatment 1261 1283	that in the fimasartan
T16	Treatment 1572 1601	higher in the fimasartan/HCTZ
T17	Treatment 1612 1629	group than in the
T18	Treatment 1819 1854	combination treatment of fimasartan
T19	Treatment 1880 1906	BP control than fimasartan
T20	Treatment 1946 1973	and tolerance to fimasartan
